from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2521/bcp

LFCtreatmentdescriptionclass of inhibitor

-0.605

Amikacinug/mL Amikacintranslation

-0.683

Cap5-10ug/mL Capreomycintranslation

-1.258

Rox10-50 ug/mL Roxithromycintranslation

-0.628

SM2-5 ug/mL Streptomycintranslation

-0.761

Tet5-10 ug/mL Tetracyclinetranslation

0.963

Rif0.2-5ug/mL Rifampicintranscription

0.902

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.659

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.395

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.482

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.703

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.304

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.297

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.558

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.640

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.133

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.094

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.146

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.047

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.491

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.376

KCN5-20 ug/mL Potassium cyaniderespiration

0.314

NaN30.2-2 mM Sodium aziderespiration

-0.529

Nigericin50 uM Nigericinrespiration

-0.021

TRC10-150 ug/mL Triclosanrespiration

-0.073

TRZ10-25 ug/mL Thioridazinerespiration

-0.878

Valinomycin0.5-10 uM Valinomycinrespiration

-1.268

ZnSO42 mM ZnSO4respiration

0.190

menadione6-10 ug/mL Menadionerespiration

0.355

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.162

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.590

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.530

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.030

NRP_1Non-replicating persistence stage 1dosRassociated

-0.676

Amp0.2mg/mL AmpicillincellWall

-0.302

Cephalexin20-100 ug/mL CephalexincellWall

-0.334

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.007

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.277

EMB10-20 ug/mL EthambutolcellWall

-0.730

Eta12-40 ug/mL EthionamidecellWall

-0.568

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.007

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.406

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.410

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.197

BZA0.12 mg/mL BenzamidearomaticAmides

0.222

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.017

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.368

H2O24 mM hydrogen peroxideDNAdamaging

0.011

Levo10 ug/mL LevofloxacinDNAdamaging

-0.028

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.917

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.156

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.178

UVUV-irradiationDNAdamaging

0.401

ARP41-4 ug/mL Antitubercular compound ARP4?

0.458

Antimycin12.5-50 ug/mL Antimycin A?

-0.094

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.177

PA_110-50 ug/mL Antitubercular compound PA-1?

0.796

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.132

PA8240.2-2 ug/mL PA-824?

0.909

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.373

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.340

Verapamil50 uM Verapamil?

0.034

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.064

methoxatin10-20 ug/mL Methoxatin?